Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve To Consider and Approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has informed BSE about a Board meeting scheduled for Tuesday, 27th May 2025 at its registered office in Hyderabad. The main agenda is to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2025, along with the auditors' limited review report. The Board will also approve the full-year audited standalone financial statements for FY25. In addition, the Board will appoint an Internal Auditor for FY 2025-26 and a Secretarial Auditor for a five-year term. The trading window for designated persons and their immediate relatives has been closed since April 1, 2025 and will remain closed until 48 hours after the board meeting concludes.
This is a routine pre-earnings intimation. The audited Q4 and FY25 results due on 27th May will be the main driver of any stock reaction. The auditor appointments are standard governance items and unlikely to move the share price on their own.